|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | C07C 231/24 | |
| C07C 233/43 | |||
| A61K 31/16 | |||
| A61P 11/08 |
| (11) | Patento numeris | 2825525 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 13711936.8 |
| Europos patento paraiškos padavimo data | 2013-03-12 | |
| (97) | Europos patento paraiškos paskelbimo data | 2015-01-21 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2018-04-25 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/GB2013/050605 |
| Data | 2013-03-12 |
| (87) | Numeris | WO 2013/136061 |
| Data | 2013-09-19 |
| (30) | Numeris | Data | Šalis |
| 201261609505 P | 2012-03-12 | US |
| (72) |
BENET-BUCHHOLZ, Jordi, ES
CER N BERTRAN, Jordi, ES
FREIXAS PASCUAL, Gloria, ES
DALMASES BARJOAN, Pere, ES
NAVARRO MUŃOZ, Isabel, ES
|
| (73) |
Laboratorios Lesvi S.L.,
Avd. Barcelona n 69, 08970 San Joan Despi (Barcelona),
ES
|
| (54) | NEW POLYMORPHIC FORM OF A LONG-ACTING BETA-2 ADRENOCEPTOR AGONIST |
| NEW POLYMORPHIC FORM OF A LONG-ACTING BETA-2 ADRENOCEPTOR AGONIST |